Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis
Thomas Condamine, … , Thomas Bauer, Dmitry I. Gabrilovich
Thomas Condamine, … , Thomas Bauer, Dmitry I. Gabrilovich
Published May 1, 2014
Citation Information: J Clin Invest. 2014;124(6):2626-2639. https://doi.org/10.1172/JCI74056.
View: Text | PDF
Research Article Immunology Article has an altmetric score of 24

ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis

  • Text
  • PDF
Abstract

Myeloid-derived suppressor cells (MDSCs) dampen the immune response thorough inhibition of T cell activation and proliferation and often are expanded in pathological conditions. Here, we studied the fate of MDSCs in cancer. Unexpectedly, MDSCs had lower viability and a shorter half-life in tumor-bearing mice compared with neutrophils and monocytes. The reduction of MDSC viability was due to increased apoptosis, which was mediated by increased expression of TNF-related apoptosis–induced ligand receptors (TRAIL-Rs) in these cells. Targeting TRAIL-Rs in naive mice did not affect myeloid cell populations, but it dramatically reduced the presence of MDSCs and improved immune responses in tumor-bearing mice. Treatment of myeloid cells with proinflammatory cytokines did not affect TRAIL-R expression; however, induction of ER stress in myeloid cells recapitulated changes in TRAIL-R expression observed in tumor-bearing hosts. The ER stress response was detected in MDSCs isolated from cancer patients and tumor-bearing mice, but not in control neutrophils or monocytes, and blockade of ER stress abrogated tumor-associated changes in TRAIL-Rs. Together, these data indicate that MDSC pathophysiology is linked to ER stress, which shortens the lifespan of these cells in the periphery and promotes expansion in BM. Furthermore, TRAIL-Rs can be considered as potential targets for selectively inhibiting MDSCs.

Authors

Thomas Condamine, Vinit Kumar, Indu R. Ramachandran, Je-In Youn, Esteban Celis, Niklas Finnberg, Wafik S. El-Deiry, Rafael Winograd, Robert H. Vonderheide, Nickolas R. English, Stella C. Knight, Hideo Yagita, Judith C. McCaffrey, Scott Antonia, Neil Hockstein, Robert Witt, Gregory Masters, Thomas Bauer, Dmitry I. Gabrilovich

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Total
Citations: 11 26 21 26 30 33 22 18 16 14 9 6 232
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2017 (16)

Title and authors Publication Year
Tumor regulation of the tissue environment in the liver
T Eggert, TF Greten
Pharmacology & Therapeutics 2017
Unfolded Protein Response of the Endoplasmic Reticulum in Tumor Progression and Immunogenicity
YS Yoo, HG Han, YJ Jeon
Oxidative medicine and cellular longevity 2017
IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer
Q Yang, X Li, H Chen, Y Cao, Q Xiao, Y He, J Wei, J Zhou
Oncogene 2017
Myeloid-Derived Suppressor Cells
DI Gabrilovich
Cancer immunology research 2017
Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer
JR Cubillos-Ruiz, SE Bettigole, LH Glimcher
Cell 2017
Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis
SL Jian, WW Chen, YC Su, YW Su, TH Chuang, SC Hsu, LR Huang
Cell Death and Disease 2017
Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation
BH Koehn, BR Blazar
Journal of leukocyte biology 2017
IRF-8 regulates expansion of myeloid-derived suppressor cells and Foxp3+ regulatory T cells and modulates Th2 immune responses to gastrointestinal nematode infection
RM Valanparambil, M Tam, PP Gros, JP Auger, M Segura, P Gros, A Jardim, TG Geary, K Ozato, MM Stevenson, P Loke
PLoS pathogens 2017
SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells
PS Redd, ML Ibrahim, JD Klement, SK Sharman, AV Paschall, D Yang, A Nayak-Kapoor, K Liu
Cancer research 2017
Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer
JR Cubillos-Ruiz, E Mohamed, PC Rodriguez
Journal for ImmunoTherapy of Cancer 2017
Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy
E Mohamed, Y Cao, PC Rodriguez
Cancer Immunology, Immunotherapy 2017
First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors
A Forero, JC Bendell, P Kumar, L Janisch, M Rosen, Q Wang, C Copigneaux, M Desai, G Senaldi, ML Maitland
Investigational New Drugs 2017
Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells
JJ Rodvold, KT Chiu, N Hiramatsu, JK Nussbacher, V Galimberti, NR Mahadevan, K Willert, JH Lin, M Zanetti
Science signaling 2017
Selective NLRP3 (Pyrin Domain–Containing Protein 3) Inflammasome Inhibitor Reduces Brain Injury After Intracerebral Hemorrhage
H Ren, Y Kong, Z Liu, D Zang, X Yang, K Wood, M Li, Q Liu
Stroke; a journal of cerebral circulation 2017
Endoplasmic reticulum stress induced LOX-1 + CD15 + polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma
J Nan, YF Xing, B Hu, JX Tang, HM Dong, YM He, DY Ruan, QJ Ye, JR Cai, XK Ma, J Chen, XR Cai, ZX Lin, XY Wu, X Li
Immunology 2017
Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies
Z Lopez-Bujanda, CG Drake
Journal of leukocyte biology 2017

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Posted by 2 X users
Referenced in 2 patents
191 readers on Mendeley
See more details